Invention Grant
US08637563B2 Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes 有权
非肽血小板生成素受体激动剂治疗癌症和癌前综合征

  • Patent Title: Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes
  • Patent Title (中): 非肽血小板生成素受体激动剂治疗癌症和癌前综合征
  • Application No.: US13487512
    Application Date: 2012-06-04
  • Publication No.: US08637563B2
    Publication Date: 2014-01-28
  • Inventor: Connie Erickson-Miller
  • Applicant: Connie Erickson-Miller
  • Applicant Address: US PA Philadelphia
  • Assignee: GlaxoSmithKline LLC
  • Current Assignee: GlaxoSmithKline LLC
  • Current Assignee Address: US PA Philadelphia
  • Agent Wayne J. Dustman; Edward R. Gimmi
  • Main IPC: A01N43/56
  • IPC: A01N43/56 A61K31/415
Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes
Abstract:
Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
Public/Granted literature
Information query
Patent Agency Ranking
0/0